DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

Summary

The Department of Defense (DoD), through the Department of the Army's U.S. Army Medical Research Acquisition Activity (USAMRAA), is soliciting applications for the Transformative Breast Cancer Consortium Development Award under the Department of Defense (DoW) Breast Cancer Research Program. This award is intended to support transformative, high-impact breast cancer research through a consortium development framework. The opportunity is posted as a synopsis on Grants.gov and is open for applications from May through July 2026.

How they evaluate

Risks & flags

• Minimal detail provided in synopsis — scope, eligibility, evaluation criteria, and award value are not disclosed, limiting competitive intelligence
• Consortium development structure may favor established research networks or institutions with pre-existing collaborative relationships